| Subject: | FDA Approves Temporary Artificial Heart |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Tue, 26 Oct 2004 - 10:00 am |
| The FDA has approved the use of a partial artificial heart approved for temporary use in patients waiting for heart transplant. The manufacturer of the device is SynCardia Systems, Inc. The artificial heart is an implantable pulsating bi-ventricular device, designed to replace the right and left ventricles, keeping blood pressure high enough to perfuse vital organs until the patient receives the necessary heart transplant. The device is intended as a "bridge to transplant" for those patients at... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
Related MCN Products:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|
